CFO
TECH icon

Callan Family Office’s Bio-Techne TECH Stock Holding History

Callan Family Office’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.56M Buy
22,045
+1,562
+8% +$84.3K 0.03% 469
2026
Q1 		$1.07M Buy
20,483
+4,143
+25% +$249K 0.02% 543
2025
Q4 		$961K Buy
16,340
+12,448
+320% +$756K 0.02% 559
2025
Q3 		$217K Buy
+3,892
New +$208K 0.01% 804

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Callan Family Office's TECH Position: Q2 2026 in Review

Callan Family Office increased its Bio-Techne (TECH) stake by 7.6% in Q2 2026, buying an estimated $84.3K and bringing the position to 22,045 shares worth $1.56M. The position accounts for 0.03% of the portfolio, ranked #469.

Callan Family Office first reported a position in TECH in Q3 2025 and has held it in 4 quarters since. 597 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Callan Family Office held 22,045 shares of Bio-Techne worth $1.56M as of Q2 2026.
  • Callan Family Office bought 1,562 Bio-Techne shares in Q2 2026, an estimated $84.3K.
  • Bio-Techne made up 0.03% of Callan Family Office's portfolio in Q2 2026, its #469 holding.
  • Callan Family Office first reported a position in Bio-Techne in Q3 2025 and has held it in 4 quarters since.
  • 597 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.